Replies to post #781086 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Makes sense I don't believe they have been in labeling phase since May-June

No I dont believe that either.
This label narrative pushed by AIslave is absolute BS given the many weeks/months that have come and gone without the great news disclosed,
In the upcoming 10Q we will most probably see the same we are engaging blabla with the MHRA.

Perhaps Flipper is right and the MHRA wanted/demanded a new comparison with the Survaxm failed trial which has delayed the review process by anotther 6 to 9 months

Flipper

They also might have, by that time, an initial analysis against another comparable ECA — Survaxm 2b trial control arm. A 91 patient intent to treat control arm (99 patients control arm total).

I think we should all prepare for a decision taken as early as November